Replimune REPL
NASDAQ REPL
$11.77 +0.05 (+0.47%)
As of: Oct 22, 2026 · 11:21 AM EDT

Replimune (REPL) Short-term Investments (2018 - 2026)

Updated

Replimune (REPL) reported Short-term Investments of $9.97 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 96.7% from $305.97 million a year earlier and down 83.3% from the prior quarter.

Analysis

Replimune (REPL) Short-term Investments (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Replimune posted Short-term Investments of $59.87 million, down 83.9% from FY2025.

  • Short-term Investments has a five-year compound annual growth rate of -27.3% (FY2021 to FY2026).
  • By fiscal year, Short-term Investments came in at $372.69 million in FY2025 (+7.6%), $346.21 million in FY2024 (-20.7%), $436.8 million in FY2023 (+50.8%) and $289.71 million in FY2022 (-1.4%).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Short-term Investments in data going back to fiscal Q4 2018.
  • Year over year, Short-term Investments has now declined in each of the last five quarters, with an average decline of 36.6% over the last eight quarters.
  • The high point for year-over-year Short-term Investments in five years was fiscal Q3 2022 (growth of 70.6%); the low point was fiscal Q1 2027 (a decline of 96.7%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $59.87 million (Q4 2026), $146.19 million (Q3 2026) and $221.35 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn
10 Replimune 1.14 Bn 81.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.97 Mn
Mar 31, 2026 59.87 Mn
Dec 31, 2025 146.19 Mn
Sep 30, 2025 221.35 Mn
Jun 30, 2025 305.97 Mn
Mar 31, 2025 372.69 Mn
Dec 31, 2024 364.29 Mn
Sep 30, 2024 318.57 Mn
Jun 30, 2024 317.47 Mn
Mar 31, 2024 346.21 Mn
Dec 31, 2023 368.68 Mn
Sep 30, 2023 420.77 Mn
Jun 30, 2023 432.62 Mn
Mar 31, 2023 436.80 Mn
Dec 31, 2022 409.71 Mn
Sep 30, 2022 282.89 Mn
Jun 30, 2022 282.84 Mn
Mar 31, 2022 289.71 Mn
Dec 31, 2021 287.90 Mn
Sep 30, 2021 275.80 Mn
API Access

Replimune Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=REPL&period=max&api_key=YOUR_API_KEY